meropenem accord 1 g inj./inf. sol. (pwdr.) i.v. vial
accord healthcare b.v. - meropenem trihydrate 1140,95 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140.95 mg - meropenem
meropenem accord 500 mg inj./inf. sol. (pwdr.) i.v. vial
accord healthcare b.v. - meropenem trihydrate 570,474 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570.474 mg - meropenem
meropenem bradex 500 mg inj./inf. sol. (pwdr.) i.v.
bradex s.a. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem
meropenem bradex 1 g inj./inf. sol. (pwdr.) i.v.
bradex s.a. - meropenem trihydrate 1140 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem
meropenem fresenius kabi 500 mg inj./inf. sol. (pwdr.) i.v. vial
fresenius kabi sa-nv - meropenem trihydrate 570 mg - eq. meropenem 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem
meropenem fresenius kabi 1 g inj./inf. sol. (pwdr.) i.v. vial
fresenius kabi sa-nv - meropenem trihydrate 1140 mg - eq. meropenem 1000,1 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem
meropenem ranbaxy 500 mg inj./inf. sol. (pwdr.) i.v. vial
ranbaxy (uk) (5) ltd. - meropenem trihydrate 570 mg - eq. meropenem anhydrous 500 mg - powder for solution for injection/infusion - 500 mg - meropenem trihydrate 570 mg - meropenem
meropenem ranbaxy 1 g inj./inf. sol. (pwdr.) i.v. vial
ranbaxy (uk) (5) ltd. - meropenem trihydrate 1140 mg - eq. meropenem anhydrous 1000 mg - powder for solution for injection/infusion - 1 g - meropenem trihydrate 1140 mg - meropenem
meropenem juno meropenem (as trihydrate) 500 mg powder for injection vial
juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 570 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia
meropenem juno meropenem (as trihydrate) 1 g powder for injection vial
juno pharmaceuticals pty ltd - meropenem trihydrate, quantity: 1140 mg - injection, powder for - excipient ingredients: sodium carbonate - meropenem juno is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:,,? community acquired lower respiratory tract infection ,,? hospital acquired lower respiratory tract infection,,? complicated urinary tract infection,,? febrile neutropaenia,,? intra-abdominal and gynaecological (poly microbial) infections,,? complicated skin and skin structure infections,,? meningitis,,? septicaemia